Becker's asked chief pharmacy officers from hospitals and health systems across the U.S. to share their focus for the remainder of the year.

Drugmakers Pfizer and Valneva are one step closer to obtaining FDA approval for what would be the first Lyme disease vaccine after publishing positive results from a phase 3 trial, the companies announced July 17.

The number of ongoing drug shortages has decreased since early 2024, but some fundamental and life-saving therapies remain in short supply. 

The second quarter of 2024 saw about a 5% decrease in hospital pharmacist job postings compared to last year, according to a report from the American Association of Colleges of Pharmacy. 

Memorial Hospital of Sweetwater County in Rock Springs, Wyo., has tapped Brendan Gemelli, PharmD, as its new pharmacy director.

The FDA is allowing Mark Cuban Cost Plus Drug Co. to temporarily import a syphilis drug that has been in shortage for more than a year. 

In June, the American Society of Health-System Pharmacists passed 16 policies on topics about artificial intelligence, independent prescribing and safe medication handling. 

Nearly 61,000 active pharmacists are certified by the Board of Pharmacy Specialties for 15 specialties. In March and April, the organization found a 63.9% average all-time pass rate among seven certification exams. 

In early June, an unknown third party impersonated a Rite Aid employee to gain access to its systems, the company said July 15. 

Yale Medicine and Yale New Haven Health System, both based in New Haven, Conn., have launched Connecticut's first mobile pharmacy.